Insider · CIK 0001627985

Beyer Pat

Reports to the SEC for 3 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001627985

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-03	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+25.1K sh	—	—	25,146
2026-06-02	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−32.3K sh	—	—	0
2026-06-02	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+32.3K sh	—	—	108,718
2026-04-01	CNMDCONMED Corp · RSUs (Restricted Stock Units)A Award	President & CEO	AAward	+28.1K sh	—	—	28,145
2026-03-02	CNMDCONMED Corp · RSUs (Restricted Stock Units)A Award	President & CEO	AAward	+28.8K sh	—	—	28,800
2026-03-02	CNMDCONMED Corp · Options To Purchase Common StockA Award	President & CEO	AAward	+68.3K sh	—	—	68,258
2025-06-03	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+32.3K sh	—	—	32,282
2025-06-02	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−26.5K sh	—	—	0
2025-06-02	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+26.5K sh	—	—	76,436
2025-01-02	CNMDCONMED Corp · Options To Purchase Common StockA Award	President & CEO	AAward	+86.4K sh	—	—	86,355
2024-06-16	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+965 sh	—	—	49,943
2024-06-16	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−965 sh	—	—	0
2024-06-11	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+26.5K sh	—	—	26,493
2024-06-07	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+30.4K sh	—	—	48,978
2024-06-07	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−30.4K sh	—	—	0
2024-04-30	CNMDCONMED CorpP Purchase	President & CEO	PPurchase	+3,000 sh	$68.30	+$205K	10,807
2024-04-24	CNMDCONMED Corp · Options To Purchase Common StockA Award	President & CEO	AAward	+20.1K sh	$70.01	+$1.4M	20,060
2024-03-01	CNMDCONMED Corp · Options To Purchase Common StockA Award	President & CEO	AAward	+44.7K sh	—	—	44,677
2023-06-16	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−965 sh	—	—	965
2023-06-16	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+965 sh	—	—	18,578
2023-06-07	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+30.4K sh	—	—	30,400
2023-06-06	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+16.6K sh	—	—	17,613
2023-06-06	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−16.6K sh	—	—	0
2023-03-01	CNMDCONMED Corp · Options To Purchase Common StockA Award	President & CEO	AAward	+32.2K sh	—	—	32,212
2022-06-17	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+16.6K sh	—	—	16,648
2022-06-16	BVSBioventus Inc.M Exercise/Conversion	Director	MExercise/Conversion	+965 sh	—	—	965
2022-06-16	BVSBioventus Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−965 sh	—	—	1,930
2022-03-01	CNMDCONMED Corp · Options To Purchase Common StockA Award	President & CEO	AAward	+55K sh	—	—	55,000
2021-11-03	CNMDCONMED CorpS Sale	President & CEO	SSale	−400 sh	$147.50	−$59K	24,854
2021-11-03	CNMDCONMED CorpS Sale	President & CEO	SSale	−10.6K sh	$148.47	−$1.57M	14,304
2021-11-03	CNMDCONMED CorpS Sale	President & CEO	SSale	−6,497 sh	$149.20	−$969K	7,807
2021-10-29	CNMDCONMED CorpS Sale	President & CEO	SSale	−2,789 sh	$144.50	−$403K	30,300
2021-10-29	CNMDCONMED CorpS Sale	President & CEO	SSale	−5,589 sh	$146.13	−$817K	7,807
2021-10-29	CNMDCONMED CorpM Exercise/Conversion	President & CEO	MExercise/Conversion	+50.7K sh	$51.30	+$2.6M	58,507
2021-10-29	BVSBioventus Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+34.9K sh	—	—	34,906
2021-10-29	CNMDCONMED CorpM Exercise/Conversion	President & CEO	MExercise/Conversion	+55.3K sh	$39.87	+$2.2M	63,107
2021-10-29	CNMDCONMED CorpF Tax Payment	President & CEO	FTax Payment	−30K sh	$144.62	−$4.34M	33,089
2021-10-29	CNMDCONMED CorpS Sale	President & CEO	SSale	−16.9K sh	$145.31	−$2.46M	13,396
2021-10-29	BVSBioventus Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,895 sh	—	—	2,895
2021-10-29	CNMDCONMED Corp · Sars (Stock Appreciation Rights)M Exercise/Conversion	President & CEO	MExercise/Conversion	−50.7K sh	—	—	0
2021-10-29	CNMDCONMED Corp · Options To Purchase Common StockM Exercise/Conversion	President & CEO	MExercise/Conversion	−55.3K sh	—	—	0
2021-10-29	CNMDCONMED CorpF Tax Payment	President & CEO	FTax Payment	−33.3K sh	$146.28	−$4.86M	25,254
2021-10-29	MISONIX INCD Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2021-05-14	MISONIX INCStock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2021-03-01	CNMDCONMED Corp · Options To Purchase Common StockA Award	President & CEO	AAward	+46.8K sh	—	—	46,750
2020-03-02	CNMDCONMED Corp · Options To Purchase Common StockA Award	President & CEO	AAward	+55K sh	—	—	55,000
2020-02-28	CNMDCONMED CorpM Exercise/Conversion	President & CEO	MExercise/Conversion	+725 sh	—	—	8,148
2020-02-28	CNMDCONMED Corp · Rsus (restricted Stock Units)M Exercise/Conversion	President & CEO	MExercise/Conversion	−725 sh	—	—	0
2020-02-28	CNMDCONMED CorpF Tax Payment	President & CEO	FTax Payment	−341 sh	$94.64	−$32.3K	7,807
2019-03-01	CNMDCONMED Corp · Rsus (restricted Stock Units)M Exercise/Conversion	President & CEO	MExercise/Conversion	−725 sh	—	—	725

Recent filings

Accepted (ET)
Jun 44
Beyer Pat0001627985-26-000002
SEC(opens sec.gov)
Apr 24
Beyer Pat0000816956-26-000041
SEC(opens sec.gov)
Mar 44
Beyer Pat0000816956-26-000013
SEC(opens sec.gov)
Jun 44
Beyer Pat0001578563-25-000302
SEC(opens sec.gov)
Jan 64
Beyer Pat0001127602-25-000752
SEC(opens sec.gov)
Jun 184
Beyer Pat0001578563-24-000303
SEC(opens sec.gov)
Jun 134
Beyer Pat0001578563-24-000284
SEC(opens sec.gov)
Jun 114
Beyer Pat0001578563-24-000265
SEC(opens sec.gov)
May 24
Beyer Pat0001127602-24-013824
SEC(opens sec.gov)
Apr 264
Beyer Pat0001127602-24-013436
SEC(opens sec.gov)
Mar 54
Beyer Pat0001127602-24-008492
SEC(opens sec.gov)
Jun 204
Beyer Pat0001578563-23-000049
SEC(opens sec.gov)

Companies

Address

4721 EMPEROR BOULEVARD, SUITE 100

DURHAM, NC, 27703